Previous 10 | Next 10 |
INOVIO (NASDAQ:INO) has announced the appointment of Dr. Michael Sumner, MB BS, MBA, as Chief Medical Officer. He will serve on the company's executive leadership team and will report to INOVIO's President and CEO, Dr. Jacqueline Shea. Dr. Sumner joins INOVIO after serving as CMO of Orex...
INOVIO Appoints Dr. Michael Sumner, MB BS, MBA as Chief Medical Officer PR Newswire PLYMOUTH MEETING, Pa. , June 27, 2022 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help protect...
Inovio Pharmaceuticals, Inc. (INO) Jefferies 2022 Global Healthcare Conference June 08, 2022 01:00 PM ET Company Participants Jacqui Shea - CEO Jeffrey Skolnik - CMO Conference Call Participants Roger Song - Jefferies Presentation Roger Song Good afternoon, everyone. Welcome to Jefferies Glob...
FTSE Russell has released a preliminary lists of companies set to join or leave the Russell Microcap Index as part of its 2022 annual reconstitution. Notable health care additions include: Inovio Pharma (INO), Bionano Genomics (BNGO), Sorrento Therapeutics (SRNE), Ocu...
Investors ought to be even more careful where they put their money in times like these. It's more important than ever to make highly selective investment decisions with a struggling stock market, challenging economic issues, and dangerous geopolitical tensions. Sure, many companies that...
When it comes to penny stocks to buy , most are usually looking for day trading opportunities. That means time frames are shorter term, in general. If you’re new to trading cheap stocks, you might be thinking about investing in them because of their low price. But it’s als...
Inovio (NASDAQ:INO +2.9%) said on Friday its therapy, INO-5401 + INO-9012, was tolerable and immunogenic when administered with Libtayo, with radiation and chemotherapy, to newly diagnosed glioblastoma patients, in an early-to-mid stage trial. The company enrolled 52 patients -...
INOVIO Announces Survival Results for INO-5401 + INO-9012 in Combination with Libtayo® (cemiplimab) in Patients with Newly Diagnosed GBM at ASCO Annual Meeting 2022 PR Newswire INOVIO's DNA medicines immunotherapy in combination with Libtayo ® elicits...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Emergent Biosolutions (NYSE: EBS ) – makes a proven smallpox vaccine that may be used for monkeypox Bavarian Nordic (OTCMKTS: BVNRY ) – boasts a monkeypox vaccine approved in the U.S. Inovio ...
GeoVax Labs (GOVX) +20%. Inovio Pharmaceuticals (INO) +19%. SIGA Technologies SIGA +15% Monkeypox plays indicate further upside as global toll climbs. O2Micro International (OIIM) +13%. GoldMining (GLDG) +12%. Emergent BioSolutions EBS +12% Monkeypox plays indicate further...
News, Short Squeeze, Breakout and More Instantly...
Inovio Pharmaceuticals Inc. Company Name:
INO Stock Symbol:
NASDAQ Market:
Inovio Pharmaceuticals Inc. Website:
Inovio Receives Advanced Therapy Medicinal Product Certificate from European Medicines Agency for Quality and Non-Clinical Data for Lead Candidate INO-3107 PR Newswire Data reviewed complies with standards that would be used to evaluate an EU Marketing Authorization Applic...
INOVIO to Report Second Quarter 2024 Financial Results on August 8, 2024 PR Newswire PLYMOUTH MEETING, Pa. , July 25, 2024 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and ...
5G leader welcomes new Chief Product Officer, Senior Vice President Sales/Service Providers and Head of Operations Inseego Corp. (Nasdaq: INSG), a technology leader in 5G mobile and fixed wireless solutions for mobile network operators, Fortune 500 enterprises, and SMBs, today announced...